Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients

Liver International

Volumn 24, Issue 1, 2004, Pages 16-20

  Nagy, Zsuzsanna ^a   Kószo, Ferenc ^b   Pár, Alajos ^a   Emri, Gabriella ^c   Horkay, Irén ^c   Horányi, Margit ^d   Karádi, Oszkár ^a   Rumi Jr , György ^a   Morvay, Márta ^b   Varga, Viktória ^c   Dobozy, Attila ^b   Mózsik, Gyula ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d National Institute of Haematology and Immunology Budapest   (Hungary)

Author keywords

Hemochromatosis gene; Hepatitis C virus; Porphyria cutanea tarda

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUNGARY; MALE; PATHOGENESIS; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PREVALENCE; RISK FACTOR;

EID: 12144287994     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.00884.x     Document Type: Article

References (34)

1. Kappas A, Sassa S, Galbraith R A. The porphyrias. In: Scriver C R, Beaudet A L, Sly W S, Valle D, eds. The Molecular and Metabolic Basis of Inherited Disease, 7th edn. New York: McGraw-Hill, 1995; 2103-59.
2. Elder G H. Porphyria cutanea tarda. Semin Liver Dis 1998; 18: 67-75.
3. Herrero C, Vincente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788-9.
4. Lacour J P, Bodokh I, Castanet J, et al. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121-3.
5. Fargion S, Piperno A, Cappellini M D, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-6.
6. Martinelli A L, Zago M A, Roselini A M, et al. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection. Am J Gastroenterol 2000; 95: 3516-21.
7. Murphy A, Dooley S, Hillary I B, et al. HCV infection in porphyria cutanea tarda. Lancet 1993; 341: 1534-5.
8. Stolzel U, Kostler E, Koszka C, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995; 21: 1500-3.
9. Gibson P R, Ratnaike S, Blake D, et al. Porphyria cutanea tarda and hepatitis C (letter). Med J Aust 1995; 162: 54.
10. Bonkovsky H L, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998; 27: 1661-9.
11. Bonkovsky H L, Banner B F, Rothman A L. Iron and chronic viral hepatitis. Hepatology 1997; 25: 759-68.
12. Roberts A G, Whatley S D, Morgan R R, et al. Increased frequency of the hemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
13. Santos M, Clevers H C, Marx J M. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda. N Engl Med 1997; 336: 1327-8.
14. Feder J N, Gnirke A, Thomas W, et al. A novel MHC class 1-like gene is mutated in patients with hemochromatosis. Nat Genet 1996; 13: 399-408.
15. Ivanova A, von Ahsen N, Adjarov D, et al. C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria. Hepatology 1999; 30: 1531-2.
16. Furuyama K, Kondo M, Hirata K, et al. Axtremly rare association of HFE mutations with porphyria cutanea tarda in Japanese patients. Hepatology 1999; 30: 1532-3.
17. Stuart K A, Busfield F, Jazwinska E C, et al. The C282Y mutation in the hemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-9.
18. Bulaj Z J, Phillips J D, Ajioka R S, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphytria cutanea tarda. Blood 2000; 95: 1565-71.
19. Ippen H. Treatment of porphyria cutanea tarda by phlebotomy. Semin Hematol 1977; 2: 8-9.
20. Seubert S, Seubert A, Ippen H. A new fast method for insolation of porphyrins using HPTLC (high performance thin layer chromatography). Dtsch Med Wochenschr 1979; 104: 1459.
21. Garson J A, Tedder R S, Briggs M, et al. Detection of hepatitis C viral sequences in blood donation by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990; 1: 1419-22.
22. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215-23.
23. Mullighan C G, Bunch M, Fanning G C, et al. A rapid method of haplotyping HFE mutation and linkage disequilibrium in Caucasoid population. Gut 1998; 42: 56-8.
24. Andrikovics H, Klein I, Kalmár L, et al. A new method of molecular testing in the differential diagnosis of hereditary hemochromatosis. Orv Hetil 1999; 140: 2517-22.
25. Pár A, Gervain J, Gógl Á. Hepatitis C virus infection: pathogenesis, diagnosis and treatment. Scand J Gastroenterol 1998; 33(Suppl 228): 107-14.
26. Bukh J, Miller R, Purcell R H. Genetic heterogeneity of hepatitis C virus: quasi-species and genotypes. Semin Liver Dis 1995; 15: 41-63.
27. Schiff E. Hepatitis C and alcohol. Hepatology 1997; 26: 39-42.
28. Fargion S, Fracanzari A L, Romano R, et al. Genetic hemochromatosis in Italian patients with porpyria cutanea tarda: possible explanation for iron overload. J Hepatol 1996; 24: 564-9.
29. Gindhart T D. Liver tumors and oral contraceptives: pathology and pathogenesis. Ann Clin Lab Sci 1978; 8: 443-6.
30. Lindberg M C. Hepatobiliary complications of oral contraceptives. J Gen Intern Med 1992; 7: 199-209.
31. Olynyk J K, Cullen D J, Aquilla S, et al. A population-based study of clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24.
32. Beutler E, Felitti V J, Koziol J A, et al. Penetrance of 845G?A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359: 211-8.
33. Simon N, Hunyadi J, Szörényi Á, et al. Porphyria cutanea tarda - eine multifaktoriell vererbliche Erkrankung? Eine Arbeitshypothese. Hautarzt 1978; 378-82.
34. Elder G H. Porpbyria cutanea tarda: a multifactorial disease. Rec Adv Dermatol 1990; 8: 55-69.